. Après-avis-de-la-commission-nationale-de-pharmacovigilance, Agence française de sécurité sanitaire des produits de santé (Afssaps) a décidé de suspendre l'autorisation de mise sur le marché (AMM) de la spécialité pharmaceutique EXOLISE®. Un retrait de tous les lots disponibles sur le marché, accompagné d'une information aux pharmaciens d'officine, 2003.

A. S. , M. H. , K. K. , R. J. , C. Pl et al., Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production, Proc Natl Acad Sci U S A, vol.105, issue.38, pp.14692-14699, 2008.

A. G. , Y. Kj, C. M. , K. Ni, and R. Rm, (-)-Epigallocatechin-3- gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma, Biochem Biophys Res Commun, vol.302, issue.2, pp.409-423, 2003.

A. Medicine, Green tea. Monograph, Altern Med Rev, vol.5, issue.4, pp.372-375, 2000.

A. H. , F. T. , N. H. Bessho-h, S. H. Hashimoto-t, and K. K. , Anti-obesity actions of green tea : possible involvements in modulation of the glucose uptake system and suppression of the adipogenesis-related transcription factors, Biofactors, vol.22, pp.1-4135, 2004.

C. T. Banerjee-b, Therapeutic Effects of Tea, p.206, 2005.

B. Nadia, Le thé : La culture chinoise du thé. 2 e édition, Editions Stéphane Bachès, pp.3-143, 2004.

B. Sj and G. Gk, A functional food product for the management of weight, Crit Rev Food Sci Nutr, vol.42, issue.2, pp.136-78, 2002.

B. Jean and . Pharmacognosie, Phytochimie : Plantes médicinales. 3 e édition, Paris : Editions TEC & DOC, Cachan : Editions Médicales Internationales, pp.239-249, 1999.

C. Hh, C. Y. , H. I. , C. Ja, S. F. et al., Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals, Clin Cancer Res, vol.9, issue.9, pp.3312-3321, 2003.

C. Hh, H. Ia, V. Dr, C. Ja, R. J. et al., Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals, Clin Cancer Res, vol.11, issue.12, pp.4627-4660, 2005.

C. Sara, . Thé, and . Santé, Le thé : de la feuille à la tasse, Cah. Nutr. Diét, vol.35, issue.1, pp.9-11, 2000.

D. A. Hodgson-jm, D. Im, and P. Rl, Tea drinking is associated with benefits on bone density in older women, Am J Clin Nutr, vol.86, issue.4, pp.1243-1250, 2007.

D. C. , W. Kr, and W. Ms, Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea, Am J Physiol Regul Integr Comp Physiol, vol.292, pp.77-85, 2006.

D. K. , K. Emr, V. N. , and W. Ms, Metabolic effects of green tea and of phases of weight loss, Physiol Behav, vol.87, issue.1, pp.185-91, 2006.

D. Ag, D. C. , R. D. , G. L. , M. N. et al., Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans

D. Ag, G. Ca, C. A. Horton-t, and M. Ds, Normal caffeine consumption : influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers, Am J Clin Nutr, vol.49, pp.44-50, 1989.

D. Ag, S. J. , G. L. , C. P. , and V. J. , Green tea and thermogenesis : interactions between catechin-polyhenols, caffeine and sympathetic activity, Int J Obes Relat Metab Disord, vol.24, issue.4, pp.252-260, 2000.

E. Marvin, Les secrets de santé du thé, pp.14-17, 2007.

G. G. , L. A. Sultan-am, and O. Pj, Cellular and in vivo hepatotoxicity caused by green tea and phenolic acids and catechins, Free Radic Biol Med, vol.40, issue.4, pp.570-80, 2006.

G. Yt, M. Jk, B. Wj, J. Bt, D. Qt et al., Reduced risk of oesophagal cancer associated with green tea consumption, J Natl Cancer Inst, vol.86, issue.11, pp.855-863, 1994.

G. L. Lydia and . Thé, Genève : Aubanel, une marque des éditions Minerva, pp.10-15, 2006.

G. Ra, H. Mg, B. Ha, . Van-poppel-g, . Van et al., Consumption of black tea and cancer risk : a prospective cohort study, J Natl Cancer Int, vol.88, issue.2, pp.93-100, 1996.

G. Joerg and . Thomas, PDR for herbal medicines, Fourth Edition, Muntvale : Edition Thomson, pp.414-422, 2007.

G. Dr, MACH-CHIEU (Dr) Pharmacopée et Médecine traditionnelle chinoise : Plantes chinoises ? Plantes occidentales. 1 e édition, Editions Présence, pp.502-503, 1986.

G. Q. Zhao-b, L. M. Shen-s, and X. W. , Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes, Biochim Biophys Acta. December, vol.1304, issue.3, pp.210-232, 1996.

G. S. , C. T. , G. Dk, and G. Ak, Anticlastogenic effects of black tea (World blend) and its two active polyphenols theaflavins and thearubigins in vivo in Swiss albino mice, Life Sci.October, vol.69, issue.23, pp.27535-27579, 2001.

H. Tm, A. Dd, G. S. , A. N. , L. Ms et al., Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea, Proc Natl Acad Sci U S A, vol.96, issue.8, pp.4524-4533, 1999.

H. Vm, M. Hm, and K. Kt, Tea drinking and bone mineral density in older women, Am J Clin Nutr, vol.71, pp.1003-1010, 2007.

H. Pc, . Van-het-hof, T. Kh, K. Lb, and . Mb, Addition of milk does not affect the absorption of flavonols from tea in man, Free Radic Res, vol.34, issue.3, pp.297-300, 2001.

H. Youyu, The Healing Power of Chinese Herbs and medicinal recipes, 2005.

I. R. , F. Y. , H. Y. , M. T. , K. T. et al., A prospective study of green tea consumption and oral cancer incidence in Japan, Ann Epidemiol. October, vol.17, issue.10, pp.821-827, 2007.

I. J. and K. Sm, Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal Caco-2 cells, Chem Biol Interact, vol.169, issue.2, pp.91-99, 2007.

J. Bt, C. Wh, H. Aw, D. Q. Mclaughlin-jk, G. Yt et al., Green tea consumption and the risk of pancreatic and colorectal cancer, Int J Cancer, vol.70, issue.3, pp.255-263, 1997.

J. L. , X. Lp, L. Ah, and B. Cw, Protective effects of green tea against prostate cancer : a case-control study in southeast China, Int J Cancer, vol.108, issue.1, pp.130-135, 2004.

K. Sk, Tea antioxidants in cancer chemoprevention, J Cell Biochem Suppl, vol.27, pp.56-67, 1997.

K. E. , L. M. , N. I. , and W. Ms, Effects of green tea on weight maintenance after body-weight loss, Br J Nutr, vol.91, pp.431-438, 2004.

K. Yukiaki, Health effects of tea and its catechines. First Edition, p.118, 2004.

K. Ja, M. Pc, G. Mcneill, and D. Gg, Effects of infusion time and addition of milk on content and absorption of polyphenols from black tea, J Agric Food Chem, vol.55, issue.12, pp.4889-94, 2007.

. Landry-yves and . Jean-pierre, Pharmacologie : des cibles vers l'indication thérapeutique, Première Edition, p.202, 2003.

L. Sc, Antioxidant potential of green and black tea determined using the ferric reducing power (FRAP) assay, Int J Food Sci Nutr, vol.51, issue.3, pp.181-189, 2000.

L. Moniteur and D. Pharmacies, Cahier II du n° 2642 du 23 septembre, 2006.

L. Mj, M. Cl, M. X. , B. Fy, P. S. et al., Pharmacokinetics of tea catechins after ingestion of green tea and (-)- epigallocatechin-3-gallate by humans : formation of different metabolites and individual variability, Cancer Epidemiol Biomarkers Prev. October, vol.1110, issue.1, pp.1025-1057, 2002.

L. C. , L. Mj, S. S. , M. X. , P. S. et al., Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion, Chem Res Toxicol, vol.13, issue.3, pp.177-84, 2000.

L. W. , A. M. , L. J. , Y. H. , S. Ae et al., A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1, PLoS ONE, vol.2, issue.11, p.1153, 2007.

L. Yc, L. Sh, S. Mh, Y. K. , Y. Jh et al., Growth inhibition and apoptosis by (-)-epigallocatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells, Eur J Cancer. December, vol.42, issue.18, pp.3260-66, 2006.

L. Cl, H. Hc, and L. Jk, Theaflavines attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells, Journal of Lipid Research, vol.48, pp.2334-2343, 2007.

L. Yp, L. Y. , X. Jg, P. Qy, L. J. et al., Topical application of caffeine or (-)-epigallocatechine gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice, Proc Natl Acad Sci, vol.99, pp.12455-12460, 2002.

L. U. and K. M. Bauer-g, Botanique : traité fondamental. 3e édition, pp.212-221

M. T. , L. L. , and B. Wb, The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus : double-blind randomized study, Metabolism, vol.56, issue.1, pp.1340-1344, 2007.

M. Jean and . Dr, Pharmacognosie et Phytothérapie Orientale

M. G. , M. , M. Pa, C. F. , R. R. et al., Hepatotoxicity from green tea : a review of the literature and two unpublished cases, Eur J Clin Pharmacol, vol.65, issue.4, pp.331-372, 2009.

M. Dennis, J. Phd-), H. Jones-kenneth, and . Kerry, MSc), with HUMPHREY Sheila (IBCLC) Botanical Medicines : The Desk Reference for Major Herbal Supplements, pp.597-656, 2002.

M. A. , P. C. , H. Y. , and K. Sk, Exceptionally high protection of photocarcinogenesis by topical application of (-)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model : relationship to inhibition of UVBinduced global DNA hypomethylation, Neoplasia. November, vol.5, issue.6, pp.555-565, 2003.

M. Jean, Guide de l'amateur de thé, pp.4-287, 1999.

P. F. , R. A. Henke-m, M. Wh, and F. B. , The effects of tea on proinflammatory signalling, BMC Med, vol.4, p.28, 2006.

P. Db, L. C. , Z. A. , G. K. , P. N. et al., Long-term tea intake is associated with reduced prevalence of (type 2) diabetes mellitus among elderly people from mediterranean islands : MEDIS epidemiological study, Yonsei Med J, vol.50, issue.1, pp.31-38, 2009.

P. Vl, K. Vpcm, D. P. , Y. H. , and S. N. , Comparative evaluation of antiproliferative, antiangiogenic and apoptosis inducing potential of black tea polyphenols in the hamster buccal pouch carcinogenesis model, J Carcinogen, vol.6, p.19, 2007.

. Pharmacopée-française, . Xe-Édition, . Paris, S. A. Maisonneuve, . Editeur81 et al., Epicatechins Purified from green tea (Camellia sinensis) differentially suppress growth of gender-dependent human cancer cell lines. Evid Based Complement Alternat Med, pp.237-247, 2006.

R. L. Prior and G. Cao, Antioxidant Capacity and Polyphenolic Components of Teas: Implications for Altering In Vivo Antioxidant Status1, Proceedings of the Society for Experimental Biology and Medicine, vol.220, issue.4, pp.255-261, 1999.
DOI : 10.1046/j.1525-1373.1999.d01-44.x

R. Ivan and A. , Medicinal Plants of the World Chemical Constituents, Traditional and Modern Medicinal Uses, pp.1-27, 2005.

R. M. , T. I. , I. G. Palumbo-r, G. G. , and R. Gl, Dietary phytochemicals in chemoprevention of cancer, Curr Med Chem -Immun, Endoc & Metab Agents. November, vol.5, pp.61-72, 2005.

S. Mr, H. D. , Z. L. Beatty-p, E. D. , E. R. et al., Inhibition of fibroblast growth factors by green tea, Int J Oncol, vol.21, issue.3, pp.487-91, 2002.

S. Mr, H. D. Shao-zm, Z. L. Beatty-p, L. C. , E. L. et al., Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells, J Nutr, vol.132, issue.8, pp.2307-2318, 2002.

S. Js, K. Mh, K. Yh, R. Jk, R. C. et al., Chemoprevention effect of green tea (Camellia sinensis) among cigarette smokers, Cancer Epidemiol Biomarker Prev, vol.4, issue.4, pp.387-91, 1995.

S. Bruno, Caféine et vigilance, Pour la science, pp.47-52, 2002.

S. Rodolph-eduard, . Vincent, and . Murielle, Botanique systématique des plantes à fleurs : Une approche phylogénétique nouvelle des Angiospermes des régions tempérées et tropicales. 2 e édition, Presses Polytechniques et Universitaires romandes, pp.296-297, 2002.

S. M. , O. S. , O. M. , T. Y. Ito-h, and F. H. , Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol in mouse tissue, Carcinogenesis. October, vol.19, issue.10, pp.1771-1777, 1998.

S. M. , Y. K. , L. Sh, M. Mf, E. Te et al., A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer, Gastroenterology, vol.134, issue.7, pp.1972-1980, 2008.

S. Sean and C. , Martindale The Complete Drug Reference. Thirty-third Edition, pp.761-763, 2002.

T. Gl, L. Tm, H. Mw, and F. Ml, Green tea polyphenols as an antioxidant and anti-inflammatory agent for cardiovascular protection, Cardiovasc Hematol Disord Drug Targets, vol.7, issue.2, pp.135-179, 2007.

T. S. , N. Y. , K. S. , H. Cc, S. H. et al., Green tea and risk of gastric cancer in Japan, N Engl J Med, vol.344, issue.9, pp.632-638, 2001.

V. B. , R. Lg, and E. , Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblastic-like cells, J Nutr Biochem, vol.18, issue.5, pp.341-348, 2007.

V. Ma and N. A. Hasan-m, Molecular targets for green tea in prostate cancer prevention, J. Nutr, vol.133, pp.2417-2424, 2003.

V. , L. Vidal, Y. E. Wada-a, and H. T. , Helicobacter pylori vacuolating cytotoxin, VacA, is responsible for gastric ulceration, J Biochem, vol.100, issue.1366, pp.741-746, 2004.

W. H. , Z. S. , Z. R. , L. W. , and S. Ae, Therapeutic potential of HMGB1- targeting agents in sepsis, Expert Rev Mol Med, vol.10, p.32, 2008.

W. L. Le-thé-et-la-culture-chinoise, 1 e édition, Chine : Editions en Langues Etrangères Beijing, pp.5-14, 2006.

W. C. Le-thé, Joyau de l'Empire du Milieu, Paris : Editions Quimétao, pp.7-8, 2007.

W. Ms, L. Mp, and K. Em, Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation

W. Max and A. Robert, Plantes thérapeutiques : Tradition, pratique officinale, science et thérapeutique. 4 e édition allemande, 2 e édition française, Editions Médicales Internationales, pp.550-553, 2003.

W. Ch, Y. Y. , Y. Wj, L. Fh, W. Js et al., Epidemiological evidence of increased bone mineral density in habitual tea drinkers, Arch Intern Med, vol.162, issue.9, pp.1001-1007, 2002.

W. Pf, C. Ta, W. Lf, C. Cs, and K. Yc, Nitro-polycyclic aromatic hydrocarbon contents of fumes from heated cooking oils and prevention of mutagenicity by catechin, Mutat Res, vol.403, issue.12, pp.29-34, 1998.

Y. Y. , W. Y. , T. Q. , H. Y. , Y. Tk et al., Efficacy of Polyphenon E, red ginseng, and rapamycin on benzo(a)pyrene-induced lung tumorgenesis in A/J Mice, Neoplasia, vol.8, issue.1, pp.52-58, 2006.

Y. Cs, C. L. , L. Mj, B. D. , K. Mc et al., Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidemiol Biomarkers Prev, vol.7, issue.4, pp.351-355, 1998.

Y. Cs, J. J. , L. G. , X. H. Hao-x, S. S. et al., Cancer prevention by tea polyphenols, Asia Pac J Clin Nutr, vol.17, issue.1, pp.245-248, 2008.

Y. Cs, L. Mj, C. L. , and Y. Gy, Polyphenols as inhibitors of carcinogenesis, Environ Health Perspect, vol.105, issue.4, pp.945-954, 1997.

Y. Cs, L. Mj, and C. L. , Human salivary tea catechin levels and catechin esterase activities : implication in human cancer prevention studies, Cancer Epidemiol Biomarkers Prev, vol.8, issue.1, pp.83-92, 1999.

Y. Yc, L. Fh, W. Js, W. Ch, and C. Cj, The protective effect of habitual tea consumption on hypertension, Arch Interm Med, vol.164, pp.1534-1574, 2004.

Y. A. , O. Da, A. Kjc, D. Yj, and G. , Mécanisme de l'action digitalique de la fraction 3 de Maï-Bao (Camellia sinensis (thé), Candida mycoderma, Acetobacter xylinum) sur le coeur isolé de rat, Ethnopharmacologia. Décembre, vol.38, pp.71-76, 2006.

Y. Jh, L. Y. , and Y. Xy, Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f]quinoline in mice, Mol Med, vol.14, pp.9-10590, 2008.

Z. M. Holman-cd, H. Jp, and X. X. , Green tea and the prevention of breast cancer : a case-control study in Southeast China, Carcinogenesis, vol.28, issue.5, pp.1074-1082, 2007.

Z. Yong-sumao, C. Shu-jun, and C. Miao-ian, Tea : Bioactivity and Therapeutic Potential, Medicinal and Aromatic Plants ? Industrial Profiles, p.267, 2002.

C. Marion, Le thé à l'officine, Thèse : Pharmacie, pp.1-54, 2007.

C. Nadine, Le thé : Historique, Composition et Nouvelles Perspectives Thérapeutiques, Thèse : Pharmacie : Clermont I : 2005, pp.1-140

G. Emile, Sources et interêt de la théanine présente dans le thé et ses préparations, Thèse : Pharmacie : Université de Rennes I, pp.1-85, 2006.

K. Stéphane, Le théier, Camellia sinensis : Données pharmacologiques récentes, Thèse : Pharmacie, pp.2-162, 2005.

M. Aurélie, Etude de la composition minérale et organique des liqueurs de thé et de leurs caractéristiques organoleptiques : Influence des paramètres physico-chimiques de l'eau, 213 p, Thèse : Sciences de la Matière : Institut National de Polytechnique de Toulouse, 2007.